Jiang Tianyi 4
4 · AvePoint, Inc. · Filed Mar 18, 2026
Research Summary
AI-generated summary of this filing
AvePoint (AVPT) CEO Jiang Tianyi Receives RSU Award
What Happened
- Jiang Tianyi, Chief Executive Officer of AvePoint (AVPT), was granted equity awards on March 16, 2026. The Form 4 shows two awards: 147,338 restricted stock units (RSUs) reported at $0 per share and 252,609 performance-based RSUs (PRSUs) with a grant-date fair value of $10.52 each (aggregate $2,657,447).
- These are awards (code A) — not open-market purchases or sales. The PRSUs are contingent on future performance metrics and will vest only if performance targets are met and certified.
Key Details
- Transaction date: 2026-03-16; Form 4 filed: 2026-03-18 (filed within two business days).
- Awards: 147,338 RSUs @ $0; 252,609 PRSUs @ $10.52 (grant-date value $2,657,447). Total units granted: 399,947.
- Shares owned after transaction: Not specified in the provided excerpt; F3 indicates the filing reports aggregate vested and unvested RSUs and other common stock holdings previously disclosed.
- Notable footnotes:
- F1: RSUs represent the contingent right to one share upon vesting.
- F2: PRSUs payout depends on two metrics — ARR CAGR for 2026–2028 (70% weight) and FY2028 GAAP profitability (30% weight); actual payout may range from 50% to 200% of granted value and will vest upon Compensation Committee certification after the performance period ends.
- F4/F5 in the filing describe existing option holdings and vesting schedules; no option exercise was reported in this transaction.
Context
- These awards are compensation grants and do not represent an immediate purchase or sale. PRSUs are performance-contingent, so their ultimate share delivery and value depend on future results and committee certification.
- For retail investors, grants signal management compensation alignment with company performance goals but are not direct evidence of the CEO buying or selling company stock.
Insider Transaction Report
Form 4
AvePoint, Inc.AVPT
Jiang Tianyi
DirectorChief Executive Officer
Transactions
- Award
Common Stock
[F1][F2][F3]2026-03-16+147,338→ 2,299,627 total - Award
Stock Option (Right to Buy)
[F4][F5]2026-03-16$10.52/sh+252,609$2,657,447→ 2,756,670 totalExercise: $10.52From: 2027-03-16Exp: 2036-03-16→ Common Stock (252,609 underlying)
Footnotes (5)
- [F1]This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F2]Represents performance-based RSUs ("PRSUs") based upon two metrics: Annual recurring revenue compounded annual growth rate for the years 2026-2028 (70% weighted) and FY 2028 GAAP profitability (30% weighted). Actual payouts may represent 50% to 200% of granted value. These PRSUs will fully vest upon certification of the actual payouts by the Issuer's Compensation Committee after the performance period ends.
- [F3]Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024, and March 18, 2025.
- [F4]This security represents options to purchase the Issuer's common stock granted to the reporting person under the Issuer's 2021 Equity Incentive Plan. Each option represents the contingent right to receive, upon exercise of the option, one share of the Issuer's common stock.
- [F5]25% of the shares underlying these options will vest on March 16, 2027, and the remaining options vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.
Signature
/s/ Brian Michael Brown, Attorney-in-Fact|2026-03-18